Apr 11 |
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
|
Apr 3 |
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
|
Mar 29 |
Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?
|
Mar 8 |
Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
|
Mar 1 |
Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?
|
Feb 28 |
Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?
|
Feb 22 |
Athira Pharma GAAP EPS of -$3.09 beats by $0.25
|
Feb 22 |
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
|
Feb 15 |
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)
|
Feb 8 |
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
|